{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:40:08Z","timestamp":1784806808422,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtct.2025.10.037","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:59:53Z","timestamp":1762617593000},"page":"484.e1-484.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-3213","authenticated-orcid":false,"given":"C. Arianne","family":"Buchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Agbayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Hueniken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-1501","authenticated-orcid":false,"given":"Abi","family":"Vijenthira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-3390","authenticated-orcid":false,"given":"Annette E.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Assouline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaris","family":"Balitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1364-5030","authenticated-orcid":false,"given":"Joy","family":"Mangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-8764","authenticated-orcid":false,"given":"Anthony","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Sehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-1934","authenticated-orcid":false,"given":"Heather","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6552-6650","authenticated-orcid":false,"given":"Corey","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-5293","authenticated-orcid":false,"given":"Allison M.","family":"Wilkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1431-8958","authenticated-orcid":false,"given":"Tamara","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinn","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7453-7922","authenticated-orcid":false,"given":"Angela M.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bredeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Kekre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3261-8289","authenticated-orcid":false,"given":"David","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-3499","authenticated-orcid":false,"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9553-4340","authenticated-orcid":false,"given":"Sita","family":"Bhella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jtct.2025.10.037_bib0001","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.bbmt.2017.06.006","article-title":"Measuring immune response to commonly used vaccinations in adult recipients of allogeneic hematopoietic cell transplantation","volume":"23","author":"Kennedy","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.10.037_bib0002","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.10.037_bib0003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3324\/haematol.2021.279216","article-title":"Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies","volume":"107","author":"Gurion","year":"2022","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.jtct.2025.10.037_bib0004","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/bloodadvances.2021005094","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma","volume":"5","author":"Perry","year":"2021","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jtct.2025.10.037_bib0005","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ccell.2021.06.014","article-title":"Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma","volume":"39","author":"Van Oekelen","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.jtct.2025.10.037_bib0006","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjh.17918","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients","volume":"196","author":"Shem-Tov","year":"2022","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.jtct.2025.10.037_bib0007","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.3390\/cancers13236140","article-title":"Vaccine responses in adult hematopoietic stem cell transplant recipients: a comprehensive review","volume":"13","author":"Janssen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtct.2025.10.037_bib0008","unstructured":"Public Health Agency of Canada. Immunization of immunocompromised persons: Canadian Immunization Guide. July 18, 2007. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-persons.html. Accessed August 19, 2025."},{"issue":"3","key":"10.1016\/j.jtct.2025.10.037_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged \u226519 years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.037_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2022.11.005","volume":"86","author":"Miller","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.jtct.2025.10.037_bib0011","unstructured":"Public Health Agency of Canada. Pneumococcal vaccines: Canadian Immunization Guide. July 18, 2007. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-16-pneumococcal-vaccine.html. Accessed September 11, 2025."},{"key":"10.1016\/j.jtct.2025.10.037_bib0012","unstructured":"Public Health Agency of Canada. Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada [2021-10-29]. November 5, 2021. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/national-advisory-committee-on-immunization-naci\/recommendations-use-covid-19-vaccines\/statement-guidance-booster-doses.html. Accessed September 11, 2025."},{"key":"10.1016\/j.jtct.2025.10.037_bib0013","unstructured":"Public Health Agency of Canada. Guidance on the use of COVID-19 vaccines for 2025 to summer 2026. January 21, 2025. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-statement-guidance-covid-19-vaccines-2025-summer-2026.html. Accessed June 11, 2025."},{"key":"10.1016\/j.jtct.2025.10.037_bib0014","unstructured":"Public Health Agency of Canada. Guidance on the use of COVID-19 vaccines during the fall of 2024. May 3, 2024. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-guidance-covid-19-vaccines-fall-2024.html. Accessed August 19, 2025."},{"issue":"49","key":"10.1016\/j.jtct.2025.10.037_bib0015","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15585\/mmwr.mm7349a2","article-title":"Use of additional doses of 2024\u20132025 COVID-19 vaccine for adults aged \u226565 years and persons aged \u22656 months with moderate or severe immunocompromise: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2024","volume":"73","author":"Roper","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtct.2025.10.037_bib0016","unstructured":"UK Health Security Agency. COVID-19: the green book chapter. September 9, 2025. Available at:https:\/\/www.gov.uk\/government\/publications\/covid-19-the-green-book-chapter-14a. Accessed October 3, 2025."},{"key":"10.1016\/j.jtct.2025.10.037_bib0017","unstructured":"Public Health Agency of Canada. COVID-19 vaccines: Canadian Immunization Guide. December 23, 2021. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-26-covid-19-vaccine.html. Accessed October 6, 2025."},{"issue":"24","key":"10.1016\/j.jtct.2025.10.037_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.041","article-title":"COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies","volume":"42","author":"Bhella","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.037_bib0019","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12985-024-02375-1","article-title":"Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis","volume":"21","author":"Sharifi Aliabadi","year":"2024","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.037_bib0020","doi-asserted-by":"crossref","first-page":"706.e1","DOI":"10.1016\/j.jtct.2023.08.008","article-title":"Immunogenicity and safety of booster SARS-CoV-2 mRNA vaccine dose in allogeneic hematopoietic stem cell transplantation recipients","volume":"29","author":"Mittal","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.10.037_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101983","article-title":"SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study","volume":"59","author":"Hill","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.037_bib0022","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/cid\/ciae291","article-title":"SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T-cell therapy: a prospective, multicenter, observational study","volume":"79","author":"Hill","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jtct.2025.10.037_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077714","article-title":"Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination","volume":"13","author":"Keeshan","year":"2023","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jtct.2025.10.037_bib0024","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jtct.2025.10.037_bib0025","doi-asserted-by":"crossref","first-page":"e1380","DOI":"10.1002\/cti2.1380","article-title":"A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination","volume":"11","author":"Colwill","year":"2022","journal-title":"Clin Transl Immunology"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.037_bib0026","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jgo.2021.12.017","article-title":"Overview of Sankey flow diagrams: Focusing on symptom trajectories in older adults with advanced cancer","volume":"13","author":"Otto","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2025.10.037_bib0027","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/vaccines11040782","article-title":"Understanding the COVID-19 vaccine policy terrain in Ontario Canada: a policy analysis of the actors, content, processes, and context","volume":"11","author":"AlShurman","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"47","key":"10.1016\/j.jtct.2025.10.037_bib0028","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1016\/j.vaccine.2023.08.066","article-title":"Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: a Japanese multicenter observational study","volume":"41","author":"Mori","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.037_bib0029","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1097\/MPH.0000000000001340","article-title":"Comparison of immune reconstitution after allogeneic versus autologous stem cell transplantation in 182 pediatric recipients","volume":"41","author":"Wiegering","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2025.10.037_bib0030","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.jtct.2023.01.025","article-title":"Impact of donor and recipient SARS-CoV-2 vaccination or infection on immunity after hematopoietic cell transplantation","volume":"29","author":"Sherman","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.10.037_bib0031","article-title":"Combining chemotherapy with CAR-T cell therapy in treating solid tumors","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725015519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725015519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:33:53Z","timestamp":1778355233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725015519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666636725015519"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.10.037","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}